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Ischemia/reperfusion injury holds a key position in many pathological conditions such
as acute kidney injury and in the transition to chronic stages of renal damage. We
hypothesized that besides a reported disproportional activation of vasoconstrictor
response, hypoxia/reoxygenation (H/R) adversely affects endothelial dilatory systems
and impairs relaxation in renal arteries. Rat renal interlobar arteries were studied
under isometric conditions. Hypoxia was induced by application of 95% N2, 5%
CO2 for 60 min to the bath solution, followed by a 10 min period of reoxygenation
(95% O2, 5% CO2). The effect of H/R on relaxation was assessed using various
inhibitors of endothelial dilatory systems. mRNA expression of phosphodiesterase
5 (PDE5), NADPH oxidases (NOX), and nitric oxide synthase (NOS) isoforms were
determined using qRT-PCR; cGMP was assayed with direct cGMP ELISA. Acetylcholine
induced relaxation was impaired after H/R. Inhibition of the NOS isoforms with
L-NAME, and cyclooxygenases (COXs) by indomethacin did not abolish the H/R
effect. Moreover, blocking the calcium activated potassium channels KCa3.1 and
KCa2.1, the main mediators of the endothelium-derived hyperpolarizing factor, with
TRAM34 and UCL1684, respectively, showed similar effects in H/R and control. Arterial
stiffness did not differ comparing H/R with controls, indicating no impact of H/R on
passive vessel properties. Moreover, superoxide was not responsible for the observed
H/R effect. Remarkably, H/R attenuated the endothelium-independent relaxation by
sodium nitroprusside, suggesting endothelium-independent mechanisms of H/R action.
Investigating the signaling downstream of NO revealed significantly decreased cGMP
and impaired relaxation during PDE5 inhibition with sildenafil after H/R. Inhibition of PKG,
the target of cGMP, did not normalize SNP-induced relaxation following H/R. However,
the soluble guanylyl cyclase (sGC) inhibitor ODQ abolished the H/R effect on relaxation.
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The mRNA expressions of the endothelial and the inducible NOS were reduced. NOX
and PDE5 mRNA were similarly expressed in H/R and control. Our results provide new
evidence that impaired renal artery relaxation after H/R is due to a dysregulation of
sGC leading to decreased cGMP levels. The presented mechanism might contribute
to an insufficient renal reperfusion after ischemia and should be considered in its
pathophysiology.
Keywords: hypoxia, ischemia/reperfusion injury, nitric oxide, cGMP, sGC, vascular smooth muscle, relaxation
INTRODUCTION
Its function and anatomical structure render the kidney very
susceptible to ischemia/reperfusion injury (IRI). IRI has been
reported in renal transplantation and, amongst others, in the
development of acute kidney injury (AKI), diabetic nephropathy
and contrast agent-induced nephropathy (Reuter and Mrowka,
2015; Maringer and Sims-Lucas, 2016). IRI may result from
insufficient renal perfusion of different origin, followed by the re-
establishment of blood flow (Le Dorze et al., 2009). In contrast to
many other organs, where ischemia is followed by an exaggerated
flow in the reperfusion period, renal blood flow re-establishes
slowly over a period of many minutes (Schneider et al., 2010;
Cantow et al., 2017). Moreover, no-reflow phenomenon has
been described in IRI experiments (Patschan et al., 2012).
This delayed restoration of renal blood flow after ischemia
may reflect kidney specific blood vessel properties and/or
interactions of renal vasculature with the surrounding tubules.
In addition, renal vasculature may be affected by the activation
of the sympathetic nervous system and the renin–angiotensin
system (RAS) resulting in an increased vascular resistance
in IRI (Kontogiannis and Burns, 1998; Mutoh et al., 2014).
Experiments in isolated renal arteries of mice revealed increased
reactivity to angiotensin II (Ang II) after hypoxia/reoxygenation
(H/R) in the presence of norepinephrine (NE) in physiological
concentrations, supporting the idea of a concerted action of both
systems on renal vascular tone. H/R may modify vessel function
by several mechanisms. Besides the proposed disproportional
activation of vasoconstrictor systems and a potential increase
in oxidative stress including enhanced superoxide levels,
endothelial dilatory systems could be equally affected by H/R
(Jankauskas et al., 2016; Pahlitzsch et al., 2018). However,
no data exist regarding the direct influence of H/R on renal
vessel relaxation. Endothelial-derived vasoactive substances,
such as nitric oxide (NO), cyclooxygenase (COX)-synthesized
prostaglandins or the endothelial-derived hyperpolarizing factor
(EDHF) might be responsible for the vasodilatory response
following H/R. The gasotransmitter NO is a potent vasodilator
and exerts its vasodilatory effects via different pathways.
Endogenously produced NO diffuses to vascular smooth muscle
cells (VSMCs), where it initiates relaxation mainly via the soluble
guanylyl cyclase/cyclic GMP/PKG (sGC/cGMP/PKG) pathway
(Denninger and Marletta, 1999). H/R might compromise any
step of this pathway leading to impaired relaxation. Interestingly,
the effect of H/R on the balance of vasoconstriction and
relaxation is sparsely investigated in the pathophysiology of
IRI. In the present study, we aimed at investigating the vascular
effects of H/R in the presence of physiological NE concentrations
in a rat model of renal arterial vessels [interlobar arteries
(ILAs)] and studied endothelium-dependent and independent
relaxation. Results indicate that H/R impairs relaxation via
endothelium-independent mechanisms, adversely affecting
sGC/cGMP signaling. We therefore propose that unbalanced
vasodilator systems in contrast to enhanced vasoconstriction
should be reassessed concerning the pathophysiology of IRI and
considered in future studies of the renal vasculature.
MATERIALS AND METHODS
Experimental Animals
Male Sprague-Dawley rats (purchased from Charles River,
Sulzfeld, Germany) (270–400 g, 10 weeks of age, n = 140)
were included in the study. The animals were given food and
water ad libitum. They were housed in the animal house of the
Charité – Universitätsmedizin Berlin at a controlled ambient
temperature of 22◦C with 50% ± 10% relative humidity and
with a 12-h light/12-h dark cycle. Protocols and animal handling
were in accordance with the NIH Guide for the Care and
Use of Laboratory Animals. Experiments were approved by the
Office for Health and Social Matters of Berlin (Berlin, Germany,
T0061/08).
Chemicals
The following drugs were used: acetylcholine (ACh),
phenylephrine (PE), sodium nitroprusside (SNP), NE,
L-NAME (Nω-nitro-L-arginine methylester hydrochloride),
indomethacin, TRAM34 (1-[(2-chlorophenyl)diphenylmethyl]-
1H-pyrazole), UCL 1684 (6,12,19,20,25,26-hexahydro-
5,27:13,18:21,24-trietheno-11,7-metheno-7H-dibenzo [b,n]
[1,5,12,16] tetraazacyclotricosine-5,13-diium dibromide),
sildenafil citrate, 4-hydroxy-TEMPO, 8-bromoguanosine
3′,5′-cyclic monophosphate sodium salt (8-Br-cGMP) ODQ
(1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one) and DT-2
trifluoroacetate salt (DT-2). All substances were obtained from
Sigma-Aldrich (Darmstadt, Germany) with the exception
of indomethacin, ODQ (Cayman Chemical Company, Ann
Arbor, MI, United States) and sildenafil citrate (Biomol GmbH,
Hamburg, Germany). Distillated water was used to prepare
the chemical solutions, except for indomethacin, TRAM34,
UCL 1684, ODQ and sildenafil citrate, which were dissolved in
>99.7% dimethyl sulfoxide (DMSO). The final concentration
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of DMSO was below 0.1% in all of the experiments. SNP was
dissolved in distillated water immediately before start of the
experiment in lightproof tubes. Concentrations are given as final
molar concentration in the bath solution.
Preparation of Rat Interlobar Arteries
The animals were killed by decapitation under isoflurane.
The kidneys were removed immediately and placed in cold
preparation solution (146 mmol/NaCl, 4.5 mmol/l KCl, 1.2
mmol/l NaH2PO4∗2H2O, 1 mmol/l MgSO4∗7H2O, 5.5 mmol/l
glucose, 0.025 mmol/l Na (EDTA), 5 mmol/l HEPES, and 0.1
mmol/l CaCl2∗2H2O; pH 7.4). Kidneys were sliced along the
main axis of tubular and vascular structures. ILA were dissected
and arterial sections (length: 2 mm) were isolated.
Measurements of Vascular Responses
Interlobar arteries were mounted on 40-µm stainless steel wires
in a small vessel myograph (model 410A, DMT, Denmark) filled
with cold preparation solution. After mounting, the solution
was changed to experimental solution (119 mmol NaCl, 4.7
mmol/l KCl, 1.2 mmol/l KH2PO4, 1.2 mmol/l MgSO4∗7H2O,
6.1 mmol/l glucose, 25 mmol/l NaHCO3, and 2.5 mmol/l
CaCl2∗2H2O; pH 7.4). The myograph was heated up to 37◦C
under unlimited gas flow of carbogen (95% O2, 5% CO2).
Thereafter, vessels underwent a normalization procedure to an
internal circumference equivalent to 90% of that produced under
an intramural pressure of 100 mmHg. The viability of ILA was
demonstrated by application of K-PSS (123.7 mmol/l KCl, 1.2
mmol/l KH2PO4, 1.2 mmol/l MgSO4∗7H2O, 6.1 mmol/l glucose,
25 mmol/l NaHCO3 and 2.5 mmol/l CaCl2∗2H2O; pH 7.4).
Endothelial function was tested by cumulative concentration–
response relationships to ACh (10−9 to 10−5 mol/l) on arteries
precontracted with PE to 50–70% of the maximum arterial
force to K-PSS. Only arteries showing complete contraction
to K-PSS and relaxation (>70%) to ACh were used for the
subsequent experiments. In initial experiments, the effect of
pO2 on vasoreactivity was tested and ILA exposed to either
ambient O2 (21% O2) or carbogen (95% O2). For all following
experiments, ILA were exposed to hypoxic gas (95% N2, 5%
CO2) or carbogen (control) for 60 min followed by 10 min of
reoxygenation with carbogen. NE in a non-pressor concentration
(10−9 mol/l) was applied during the hypoxic and the control
situation to simulate a sympathetic activity. NE was washed
out during the reoxygenation period. Data were digitized using
PowerLab system (ADinstruments, Spechbach, Germany).
Measurements of Endothelial Dilatory
Function
Figure 1 represents a scheme to illustrate the protocols used to
investigate the endothelium-independent pathways and to affect
the NO/sGC/cGMP signaling.
L-NAME [inhibitor of endothelial NO synthase (eNOS),
inducible NOS (iNOS), and neuronal NOS (nNOS), 10−4 mol/l],
or indomethacin (inhibitor of COXs, 10−5 mol/l), or TRAM34
(KCa3.1 blocker, 10−6 mol/l), UCL 1684 (KCa2.3 blocker,
10−7 mol/l) or ODQ (sGC inhibitor, 10−5 mol/l) were
FIGURE 1 | Illustration of applied chemicals (bold) to affect the
NO/sGC/cGMP signaling pathway; SNP, sodium nitroprusside; NO, nitric
oxide; NOS, nitric oxide synthase; L-NAME, Nω-nitro-L-arginine methylester
hydrochloride; L-Arg, L-arginine; O2−, superoxide; GTP, guanosine
triphosphate; sGC, soluble guanylyl cyclase; ODQ,
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one; GMP, guanosine
monophosphate; cGMP, cyclic guanosine monophosphate; 8-Br-cGMP,
8-bromoguanosine 3’,5’-cyclic monophosphate sodium salt; PKG,
cGMP-dependent protein kinase; DT-2, DT-2 trifluoroacetate salt; PDE,
phosphodiesterase; tempol, 4-hydroxy-TEMPO. (∗) – activation, (–) – inhibition.
applied during the entire 60 + 10 min period. Immediately
after the reoxygenation period, ACh concentration–response
relationships (10−9 to 10−5 mol/l) were obtained from PE




Sodium nitroprusside was used for endothelium-independent
induction of relaxation. Concentration–response relationships
to SNP (10−9 to 10−4 mol/l) were obtained from precontracted
ILA (PE), while the endothelial dilatory systems via NOS
and COX were inhibited by L-NAME (10−4 mol/l) and
indomethacin (10−5 mol/l), respectively. To test the
role of cGMP as an important mediator of NO induced
relaxation, 8-bromoguanosine 3′,5′-cyclic monophosphate
sodium salt (10−8 to 3 × 10−4 mol/l), a stable form of
cGMP, was added to precontracted ILA. The downstream
target PKG was investigated by inhibition using DT-
2 trifluoroacetate salt (10−7 mol/l). Further, a potential
role of PDE5 for the H/R effect on relaxation was tested
by applying sildenafil citrate (10−8 to 10−5 mol/l). To
exclude an influence of oxidative stress, 4-hydroxy-TEMPO
(tempol, 10−4 mol/l) was added during the 60 + 10 min H/R
period.
Measurements of Vascular Wall Stiffness
Length-tension relationships were obtained by stretching the
vessels in 20 µm steps until the wall tension was 4.5 mN/mm after
the 60 + 10 min H/R period in order to investigate mechanical
properties of the VSMCs in ILA. The experimental data of each
vessel were fitted by using the equation T = T0 exp [beta∗(IC-
IC0)/IC0]. T is the wall tension (mN/mm), T0 is the wall tension
at the transmural pressure of 100 mmHg, IC0 is the internal
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circumference (mm) of the vessels at the transmural pressure
of 100 mmHg and IC is the internal circumference (mm) of
the vessels. The parameter beta expresses vascular wall stiffness
(Freslon and Giudicelli, 1983; Nyborg et al., 1987).
Preparation of Rat Interlobar Arteries for
Gene Expression Analysis
Isolated ILA were kept in experimental solution at 37◦C in
an oxygenation chamber and were exposed to hypoxic gas or
carbogen for 60 min followed by 10 min of reoxygenation with
carbogen. NE (10−9 mol/l) was applied during the hypoxic and
control period and was washed out during reoxygenation.
RNA Isolation and Quantitative PCR
The mRNA was promptly isolated. The tissue was homogenized
in lysis buffer (1.0% NP40, 0.5% sodium deoxycholate, 0.1%
SDS, 10 mmol/l NaF, 80 mmol/l Tris, pH 7.5) containing
enzyme inhibitors (Complete Mini; 1 tablet/1.5 ml; Roche
Diagnostics, Mannheim, Germany). RNA was isolated with
RNA-Bee-reagent (Biozol, Eching, Germany) and reverse
transcribed with random hexamers (High Capacity cDNA
RT-Kit, Applied Biosystems, Foster City, CA, United States,
#4374966), according to the manufacturer’s protocols. QPCR
was performed using a Lightcycler LC480 (Roche Diagnostics,
Mannheim, Germany), according to the manufacturer’s protocols
and with a StepOnePlus device (Applied Biosystems, Foster City,
CA, United States) using SYBR Green for fluorescent detection of
DNA generated during PCR, respectively. The expression levels
of mRNA were normalized to 18SrRNA and the housekeeping
gene RPL32, respectively (primer sequences: see Table 1).
Relative expressions to control situation were calculated by using
the 2−11Ct-method.
Analysis of Reactive Oxygen Species
Formation and Distribution
Interlobar arteries were mounted and exposed to hypoxia or
carbogen for 60 min in the presence of NE (10−9 mol/l), followed
by a reoxygenation step of 10 min. During the treatment ILA
were incubated with dihydroethidium (DHE) (2∗10−5 mol/l) for
30 min followed by wash-out. ILA were immediately frozen in
tissue tek (Sakura, Staufen, Germany). Cryosections (10 µm)
were counterstained with DAPI (4′,6-diamidino-2-phenylindole,
dihydrochloride). DHE fluorescence was captured using a
Zeiss Axiophot fluorescence microscope (Zeiss Axiovert 200M,
software Axiovision 3.0). For each vessel, DHE fluorescence was
measured in four separate cryosections (four arterial rings) and
calculated from 10 separate high power fields/image using ImageJ
software (NIH, Bethesda, MD, United States).
Direct cGMP ELISA
Interlobar arteries were isolated (see gene expression analysis)
and exposed to hypoxia or carbogen for 60 min in the presence of
NE (10−9 mol/l), followed by a reoxygenation step of 10 min. ILA
were frozen and stored at−80◦C until assay. The cGMP levels in
ILA were measured using a direct cGMP ELISA kit (Enzo Life
Sciences, Lausen, Switzerland) according to the manufacturer’s
instruction.
Statistical Analyses
EC50 were calculated by fitting the concentration–response
relationship using a non-linear four parameter logistic function.
Differences in EC50 were tested by a non-parametric Wilcoxon
test for independent variables (Sigmaplot 13.0, Systat Software
GmbH, Erkrath, Germany). If applicable, differences during the
concentration–response relationships were tested by ANOVA for
repeated measurements and non-normal distribution (Brunner
test, “R” project1). ANOVA followed by Wilcoxon test and
correction for multiple comparisons were used for testing group
differences of expression. mRNA expression data were tested by
the Mann–Whitney test. Data are presented as mean± SEM. The
n-value given in the figures corresponds to vessel number. The
confidence level P was set to 0.05.
RESULTS
Impaired Relaxation of Rat Interlobar
Arteries After H/R
To simulate the effect of H/R in the kidney, hypoxia for 60 min
and reoxygenation for 10 min were applied to isolated ILA from
rats. Initial experiments excluded adverse effects of carbogen
exposure compared to ambient pO2 on vasoreactivity of ILA
(EC50: 3.3∗10−8 mol/l (carbogen) vs. 1.7∗10−8 mol/l (21% O2),
Figure 2A).
In order to approach the in vivo situation, a non-constrictor
concentration of NE (10−9 mol/l) was applied during the hypoxic
period and the respective control period. Hypoxia in presence of
NE followed by reoxygenation decreased the sensitivity to ACh
compared to control conditions [EC50: 2.4∗10−7 mol/l (control)
vs. 4.8∗10−7 mol/l (H/R); P = 0.004, Figure 2A]. Hypoxia without
NE treatment did not affect the relaxation to ACh and NE did not
affect the ACh-induced relaxation in the control group (data not
shown).
1https://www.r-project.org/














18S rRNA ACGGACCAGAGCGAAAGCAT TGTCAATCCTGTCCGTGTCC
PDE5A GTCTGCCCAAACCCTTAAAA CGCTGTTTCCAGATCAGACA
RPL32 GAAAGAGCAGCACAGCTGGC TCATTCTCTTCGCTGCGTAGC
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FIGURE 2 | Effects of H/R and inhibitors of dilatory systems on endothelium-dependent relaxation in isolated rat renal interlobar arteries (ILAs) precontracted with
PE. (A) Carbogen (control) showed no adverse effects on relaxation compared to 21% O2. EC50 of H/R compared to control was significantly different pointing to
diminished ACh-induced relaxation following H/R [EC50: 2.37∗10−7 mol/l (control) vs. 4.75∗10−7 mol/l (H/R); P < 0.05]. Inhibiting endothelial dilatory systems (B–D)
did not reverse the effect of H/R on ILA relaxation. (B) NOS inhibition [with L-NAME, EC50: 3.33∗10−7 mol/l (control) vs. 9.54∗10−7 mol/l (H/R); P < 0.05]. The
maximum ACh-induced relaxation was further significantly different comparing H/R and control (P < 0.05; Brunner test). (C) COX inhibition [with indomethacin (Indo),
EC50: 1.63∗10−7 mol/l (control) vs. 4.00∗10−7 mol/l (H/R); P < 0.05]. (D) KCa3.1 inhibition [with TRAM34, EC50: 2.02∗10−7 mol/l (control) vs. 4.05∗10−7 mol/l
(H/R): P < 0.05] and KCa2.1 inhibition [with UCL 1684, EC50: 3.52∗10−7 mol/l (control) vs. 2.07∗10−6 mol/l (H/R): P < 0.05]. Mean ± SEM. (∗) indicates significant
differences. (E) Relative x-fold mRNA expression of nNOS, iNOS and eNOS normalized to 18SrRNA under H/R relative to control conditions. H/R significantly
decreased iNOS and eNOS mRNA expression levels. The average mRNA expression level under control conditions was arbitrarily given a value of 1 (20) (∗P < 0.05;
compared to control; Mann–Whitney Test; n = 8).
Endothelial-Dependent Dilatory Systems
Are Not Responsible for the H/R Effect
To investigate the mechanisms behind the observed diminished
vasodilatory response to H/R (hereafter: “H/R effect”), inhibitors
of main endothelium-dependent dilatory systems were applied
during the experiment. If any of the investigated systems
is responsible for the H/R effect, the respective inhibition
should align the concentration–response-relationship of control
and H/R.
Inhibition of NO synthases (NOS) with L-NAME (10−4 mol/l)
did not reverse the H/R effect [EC50: 3.3∗10−7 mol/l
(control) vs. 9.5∗10−7 mol/l (H/R); P = 0.004]. However, it
significantly reduced the maximum ACh effect [relaxation
compared to PE contraction: 62.3 ± 4.9% (control) vs.
36.2 ± 5.2% (H/R); P = 0.007 Figure 2B]. The COX
inhibitor indomethacin (10−5 mol/l) did not align the
concentration–response-relationships of control and
H/R [EC50: 1.6∗10−7 mol/l (control) vs. 4.0∗10−7 mol/l
(H/R); P = 0.005, Figure 2C]. Further, neither KCa3.1
inhibition by TRAM34 [10−6 mol/l, EC50: 2.0∗10−7 mol/l
(control) vs. 4.1∗10−7 mol/l (H/R); P = 0.005] nor KCa2.1
inhibition by UCL1684 [10−7 mol/l, EC50: 3.5∗10−7 mol/l
(control) vs. 2.1∗10−6 mol/l (H/R); P = 0.03] eliminated
the inhibitory effect of H/R on ACh-mediated relaxation
(Figure 2D).
H/R treatment resulted in a significant downregulation of
inducible NOS mRNA (0.45-fold; P = 0.025) and endothelial NOS
mRNA (0.34-fold; P = 0.026) in rat ILA (Figure 2E).
Impaired Vascular Smooth Muscle Cell
Function in Rat Interlobar Arteries
After H/R
After excluding that endothelial-dependent vasodilatory systems
are responsible for the observed H/R effect, the endothelium-
independent relaxation of ILA was investigated by application of
the NO donor SNP and simultaneous inhibition of endothelial-
dependent dilatory systems. H/R reduced the sensitivity of
ILA to SNP during simultaneous inhibition of NOS (L-
NAME, 10−4 mol/l) and COX (indomethacin, 10−5 mol/l),
compared to control condition [EC50: 3.3∗10−8 mol/l (control)
vs. 9.4∗10−8 mol/l (H/R); P = 0.01, Figure 3A], indicating
that the H/R effect is independent of NO-bioavailability, but
rather depends on an impaired VSMC function. Analysis of the
vascular wall stiffness in non-stimulated vessels did not show
significant differences between H/R treated and control vessels
(Figure 3B).
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FIGURE 3 | Effect of H/R on endothelium independent relaxation in isolated rat renal ILA. (A) H/R and simultaneous inhibition of the endothelial dilatory systems did
not reverse the effect of H/R on ILA relaxation as indicated by significantly different EC50 [3.32∗10−8 mol/l (control) vs. 9.37∗10−8 mol/l (H/R); P < 0.05]. (B) Vascular
wall stiffness parameter b (beta) did not significantly differ between both groups. Mean ± SEM. (∗) indicates significant differences.
Superoxide Does Not Contribute to the
H/R Effect
It was tested whether superoxide contributes to the impaired
relaxation of ILA after H/R. The superoxide dismutase mimetic
4-hydroxy-TEMPO (tempol) did not influence the impaired
relaxation to SNP during inhibition of the endothelium by
L-NAME (10−4 mol/l) and indomethacin [10−5 mol/l, EC50:
3.3∗10−8 mol/l (control) vs. 6.8∗10−8 mol/l (H/R); P = 0.033,
Figure 4C]. Moreover, superoxide concentration measured
by DHE fluorescence did not significantly differ between
ILA slices from H/R and control conditions and NADPH
oxidase enzymes NOX1, NOX2, NOX4 were not differentially
expressed following H/R, further indicating no major role of
oxidative stress after H/R under these experimental conditions
(Figures 4A,B,D).
H/R Attenuates the Response to
PDE5-Inhibition and Significantly
Decreases cGMP Concentration
By using the PDE5 inhibitor sildenafil and the cell-permeable
cGMP analog 8-bromoguanosine 3’,5’-cyclic monophosphate
sodium salt (8-Br-cGMP), it was investigated whether the
function of key enzymes in cGMP pathway changes under H/R.
The relaxation to the PDE5 inhibitor sildenafil (10−5 mol/l) was
reduced in ILA after H/R compared to control conditions [EC50:
1.2∗10−6 mol/l (control) vs. 7.1∗10−6 mol/l (H/R); P = 0.001,
Figure 5A]. 8-Br-cGMP (10−6 to 3∗10−4 mol/l) relaxed ILA
similarly under H/R and control conditions (Figure 5B).
The cGMP concentrations were lower after H/R compared
to the control conditions [0.52 ± 0.04 pmol/ml (control) vs.
0.29 ± 0.05 pmol/ml (H/R); P = 0.017; Figure 5C]. Moreover,
PDE5 mRNA is highly expressed in ILA, but not differentially
regulated after H/R rather pointing to a dysregulation of cGMP
production (x-fold mRNA expression H/R relative to control:
1.16± 0.12; P = 0.396).
We also tested the role of PKG, which is involved in the NO
signaling. SNP was applied while the endothelial dilator function
was inhibited by L-NAME (10−4 mol/l) and indomethacin
(10−5 mol/l). PKG inhibition by DT-2 (10−7 mol/l) did not
affect the impaired relaxation due to H/R [EC50: 2.1∗10−8 mol/l
(control) vs. 4.9∗10−8 mol/l (H/R); P = 0.013, Figure 6A].
sGC Inhibition Reverses the H/R Effect
on ILA Relaxation
Activation of the sGC enzyme via NO results in cGMP
production and vessel relaxation. Therefore, the observed
reduced cGMP levels leading to impaired relaxation might
be caused by sGC dysfunction. The sensitivity to ACh was
similar comparing H/R and control under ODQ treatment
[EC50: 8.9∗10−7 mol/l (control) vs. 1.7∗10−6 mol/l (H/R),
p = 0.281]. Thus, inhibition of sGC using the inhibitor ODQ
reverses the initially observed H/R effect on relaxation and
aligns the concentration–response relationships of control and
H/R treatment (Figure 6B). Table 2 summarizes the EC50 and
the respective maximum response of the presented small vessel
myograph experiments.
DISCUSSION
This study shows that the impaired relaxation of rat ILA
to ACh after treatment with H/R, in the presence of
physiological level of NE, is mediated by modified signaling
in VSMCs. No functional impairment of the endothelial
dilatory NOS- and COX-systems as well as EDHF was detected
under these experimental conditions. Further, PDE5 and
PKG, the downstream target of cGMP, seem not to be
responsible for the H/R effect. Noticeably, reduced cGMP
concentrations were found after H/R. We demonstrate
here that sGC dysfunction caused by H/R results in
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FIGURE 4 | Analysis of superoxide in renal rat ILA. (A) Representative images of vascular rings loaded with DHE under control conditions and after H/R treatment
(DHE concentration: 2∗10−5 mol/l, magnification: 200×; scale bar = 400 µm) (B) Analysis of DHE fluorescence showed no significant differences between both
groups. (C) H/R and simultaneous inhibition of superoxide, using the superoxide dismutase mimetic tempol, did not reverse the H/R effect on
endothelium-independent relaxation in isolated rat renal ILA precontracted with PE. [EC50: 3.34∗10−8 mol/l (control) vs. 6.75∗10−8 mol/l (H/R); P < 0.05].
(D) Relative x-fold mRNA expression of NADPH oxidase enzymes (NOX) normalized to 18SrRNA after H/R relative to control conditions. The analyzed NOX were not
differentially regulated following H/R. The average mRNA expression level under control conditions was arbitrarily given a value of 1 (20) (∗P < 0.05; compared to
control; Mann–Whitney Test; n = 8). Mean ± SEM. (∗) indicates significant differences.
impaired relaxation of ILA, which appears independent of
NO-bioavailability.
Altered renal perfusion is considered to play a key role in
the pathophysiological events following IRI. Renal vessels are
effectors as well as targets in the pathophysiological course
of ischemia and the subsequent H/R stage. The observation
of increased vasoreactivity of mouse ILA to Ang II after
H/R supports the assumption that enhanced vessel tone
contributes to IRI (Kaufmann et al., 2015; Braun et al., 2017;
Pahlitzsch et al., 2018). Since vascular tone results from the
balance of constrictor and dilator systems, it was hypothesized
that increased vasoreactivity in H/R may also result from
TABLE 2 | EC50 (mean ± SEM) and maximum response (mean ± SEM) of small vessel myograph studies; # indicates P < 0.05.






ACh-CRC 2.37∗10−7 ± 3.32∗10−8 4.75∗10−7 ± 6.29+10−8 # −82.79 ± 3.78 −75.04 ± 2.77
L-NAME+ACh-CRC 3.33∗10−7 ± 4.99∗10−8 9.54∗10−7 ± 2.43∗10−7 # −62.32 ± 4.86 −36.22 ± 5.22 #
Indo+ACh-CRC 1.63∗10−7 ± 3.23∗10−8 4.00∗10−7 ± 6.43∗10−8 # −87.78 ± 1.92 −82.06 ± 2.45
TRAM34+ACh-CRC 2.02∗10−7 ± 6.08∗10−8 4.05∗10−7 ± 8.00∗10−8 # −83.66 ± 1.75 −81.43 ± 2.15
UCL1684+ACh-CRC 3.52∗10−7 ± 6.41∗10−8 2.07∗10−6 ± 1.36∗10−6 # −87.54 ± 4.51 −76.78 ± 2.77 #
L-NAME+Indo+SNP-CRC 3.32∗10−8 ± 1.00∗10−8 9.37∗10−8 ± 2.70∗10−8 # −89.77 ± 1.82 −86.63 ± 2.45
L-NAME+Indo+Tempol+SNP-CRC 3.34∗10−8 ± 6.58∗10−9 6.75∗10−8 ± 1.53∗10−8 # −86.53 ± 2.02 −87.02 ± 1.81
Sildenafil-CRC 1.18∗10−6 ± 3.00∗10−7 7.14∗10−6 ± 2.51∗10−6 # −89.69 ± 1.91 −89.55 ± 1.30
L-NAME+Indo+DT-2+SNP-CRC 2.14∗10−8 ± 5.45∗10−9 4.88∗10−8 ± 7.91∗10−9 # −93.37 ± 1.50 −93.64 ± 1.78
ODQ+ACh-CRC 8.90∗10−7 ± 5.34∗10−7 1.70∗10−6 ± 5.68∗10−7 −20.76 ± 6.64 −3.03 ± 5.10
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FIGURE 5 | Effect of H/R on the cGMP pathway in rat renal ILA. (A) The H/R effect on ILA relaxation was not abolished by PDE5 inhibition using sildenafil as
indicated by significant differences in the EC50 [1.18∗10−6 mol/l (control) vs. 7.14∗10−6 mol/l (H/R); P < 0.05]. (B) The cGMP analog 8-Br-cGMP reversed the H/R
effect and abolished significant differences between the two groups. (C) H/R significantly decreased cGMP concentration in ILA (P < 0.05). Mean ± SEM. (∗)
indicates significant differences.
FIGURE 6 | Effect of H/R on sGC-dependent relaxation in isolated rat renal interlobar arteries (ILAs) precontracted with PE. (A) Inhibition of PKG kinase by DT-2
could not reverse H/R effect on ILA relaxation [EC50 : 2.14∗10−8 mol/l (control) vs. 4.88∗10−8 mol/l (H/R); P < 0.05]. Mean ± SEM. (∗) indicates significant
differences. (B) The sGC inhibitor ODQ abolished the H/R effect on ILA relaxation and aligned control and H/R dose–response relationships [8.90∗10−7 mol/l
(control) vs. 1.70∗10−6 mol/l (H/R); EC50 not significant, ANOVA not significant].
impaired vasodilator systems, which can mediate relaxation
via endothelial-dependent or -independent mechanisms. NO is
an important dilatory factor in the kidney and contributes to
the ACh-induced renal relaxation (Tai et al., 2004; Patzak and
Persson, 2007). Enzymatic blockade of NO synthases by L-NAME
did not prevent the reduced relaxation after H/R compared
to control but decreased the sensitivity to ACh similarly in
both groups. The maximum relaxation was smaller in H/R
compared to control. These results suggest no role of the
endothelial NO-system for reduced relaxation in H/R. However,
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our functional data point to an enhanced NO-bioavailability at
higher ACh concentrations after H/R. As reported in recent
studies, increased NO-bioavailability could be the result of an
increased NO production from nitrite under hypoxic conditions
(Feelisch et al., 2008; Liu et al., 2015). Interestingly, H/R
significantly decreased endothelial NOS and inducible NOS
expression at the transcriptional level, but this result is limited
by the lack of protein expression and activity data. A time-
dependent differential mRNA regulation of NOS enzymes cannot
be excluded.
Indomethacin, a COX pathways inhibitor, neither affected the
relaxation to ACh of ILA, nor influenced the difference in the
ACh response between H/R and control. This observation is
in line with findings in isolated rat renal arteries and isolated
perfused rat afferent arterioles (Wang et al., 2003; Grbovic et al.,
2008). In contrast, experiments in anesthetized rats revealed a 20–
40% contribution of the indomethacin inhibited systems to the
control of renal perfusion (Dautzenberg and Just, 2013). These
contrary results may reflect a different function of indomethacin
inhibitable systems in the in vivo vs. in vitro situation as well as
different expression of COX in larger arteries vs. arterioles.
Endothelium-derived hyperpolarization has been identified as
a factor for renal vessel relaxation (Edgley et al., 2008; Michel
et al., 2008; Simonet et al., 2012; Dautzenberg and Just, 2013;
Salomonsson et al., 2017). The endothelial hyperpolarization,
which is mediated by Ca2+-activated K+-channels (KCa)
initializes the EDHF-dilator response. Two KCa subtypes, namely
the intermediate-conductance KCa (KCa3.1) and the small-
conductance KCa type 2 (KCa2.1) contribute mainly to the
hyperpolarization (Grgic et al., 2009). Inhibition of KCa3.1 and
KCa2.1 with TRAM34 and UCL 1684, respectively, did not
exert significant effects on the ACh concentration–response
relationships. Most importantly the differences in ACh sensitivity
between the H/R and control group remained, suggesting no
significant role of EDHF for the H/R effect. In summary,
endothelial-dependent vasodilatory systems are not responsible
for diminished relaxation following H/R.
The H/R-induced impairment of relaxation only occurs in
vessels treated with low concentration of NE (10−9 mol/l) during
the hypoxic phase. This concentration is within the range of
physiological NE plasma concentrations (Kawada et al., 2014)
and did not affect the tone or relaxation to ACh in control vessels.
It has been shown that H/R in combination with NE (10−9 mol/l)
enhanced constriction to Ang II in mouse ILA (Kaufmann et al.,
2015). The mechanisms of the combined effect of activation of
the sympathetic system and H/R are not well understood.
An incomplete relaxation of rat arterioles in response to
the removal of NE treatment (10−5.5 mol/l) has been reported
(Martinez-Lemus et al., 2004). The incomplete relaxation was
interpreted as a mechanoadaptive mechanism of VSMCs to the
NE treatment. However, structural changes of ILA following H/R
do not appear to be important in the present study. Vessels did
not differ regarding vessel stiffness calculated by the parameter
beta comparing control and H/R group, indicating similar passive
properties.
Previous studies reported enhanced oxidative stress following
H/R, which potentiates IRI damage to the kidney and increases
vasoconstriction (Jankauskas et al., 2016; Pahlitzsch et al.,
2018). To test if oxidative stress contributed to H/R-mediated
vascular dysfunction in the present study, DHE fluorescence was
assessed. However, no difference in fluorescence was observed
when comparing H/R-treated and control vessels. Furthermore,
tempol, a superoxide dismutase mimetic, did not affect the
difference in the SNP sensitivity between vessels after H/R
and control treatment. NADPH oxidase enzymes were not
differentially regulated. Taken together, our data do not indicate
a major role of superoxide in this context. However, the
involvement of reactive oxygen species other than superoxide
cannot be excluded (Huang et al., 2016).
Treatment with the NO donor SNP dilated control vessels
in a concentration-dependent manner, and this response was
reduced in H/R-treated vessels. This observation locate the
mechanisms, by which H/R diminishes relaxation to ACh, in
the VSMCs. The main receptor for NO in VSMCs is sGC,
which catalyzes the production of cGMP. The latter activates
PKG by several cellular mechanisms leading to reduced cytosolic
calcium concentration and/or calcium sensitivity of contraction
and subsequently to vasodilation. The cGMP concentration
results from its production as well as from its degradation by
phosphodiesterases (PDE). PDE5 is strongly expressed in ILA
and may significantly contribute to the regulation of the cGMP
level. Inhibition of PDE5 by sildenafil induced relaxation of
vessels in the present study. The sensitivity to sildenafil was
reduced after H/R compared to control. To clarify if this reduced
sensitivity is due to (i) lower cGMP production by sGC, (ii)
changes in PDE5 expression, or (iii) downstream signaling,
further experiments were performed. The stable cGMP analog 8-
Br-cGMP relaxed control and H/R-treated ILA in a similar way
and, in line with previous studies, only at high concentrations
(Goulopoulou et al., 2015). Inhibition of PKG, an important
kinase downstream of cGMP, did not abolish the differences
in SNP responses between H/R and controls further locating
the H/R effect to other up- or downstream targets. Moreover,
cGMP concentrations were significantly decreased following
H/R pointing to disturbed or lower cGMP production by sGC.
Therefore, we investigated the effects of sGC inhibition on ILA
relaxation using its heme-site inhibitor ODQ. Inhibition of sGC
signaling reversed the H/R effect on ILA relaxation pointing to a
disturbed sGC signaling. Our results suggest that H/R adversely
affects sGC function leading to impaired relaxation in rat ILA.
Due to our ex vivo model of isolated vessels, limitations
occur in our study, which might influence the interpretation
of our results. In contrast to the in vivo situation, our vessels
are not exposed to a systemic or local renin-angiotensin system
(RAS) or secreted substances from surrounding or adjacent cells,
which might essentially influence vessel tone. NE was applied
to simulate sympathetic activity, as it was found to be crucial
for the reproduction of an H/R effect. Currently, there is no
adequate model available that offers accessibility of small vessels
and at the same time, closely simulates the complex in vivo
interplay of RAS, sympathetic system, vasoactive substances and
vasoreactivity. Therefore, it should be acknowledged that the
conclusion reached here refers to isolated vessels and might not
be directly transferable to in vivo situation.
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Moreover, this study is restricted to investigations of the
sGC/cGMP pathway and its role in the H/R effect of impaired
relaxation. While we could show that sGC dysfunction following
H/R leads to diminished relaxation of interlobar arteries, we did
not analyze a possible role of adenylatecyclase/cAMP signaling
in our experimental setup. It is imaginable that decreased cAMP
levels and/or a dysfunction of adenylatecyclase might contribute
to the H/R effect. This assumption warrant further investigations.
CONCLUSION
H/R impairs ACh-induced relaxation by an endothelium-
independent way in vascular smooth muscles cells. The
mechanism whereby H/R induced impaired relaxation may
include sGC dysfunction and subsequently decreased cGMP
production. The impaired relaxation due to H/R may be a
pathogenetic factor for reduced renal perfusion and delayed
reperfusion in ischemia reperfusion injury.
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